Cargando…
Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196444/ https://www.ncbi.nlm.nih.gov/pubmed/37214468 http://dx.doi.org/10.3389/fphar.2023.1213155 |
| _version_ | 1785044355374907392 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10196444 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101964442023-05-20 Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy Front Pharmacol Pharmacology Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10196444/ /pubmed/37214468 http://dx.doi.org/10.3389/fphar.2023.1213155 Text en Copyright © 2023 and Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy |
| title | Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy |
| title_full | Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy |
| title_fullStr | Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy |
| title_full_unstemmed | Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy |
| title_short | Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy |
| title_sort | erratum: stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (vegfr2) in osteosarcoma therapy |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196444/ https://www.ncbi.nlm.nih.gov/pubmed/37214468 http://dx.doi.org/10.3389/fphar.2023.1213155 |
| work_keys_str_mv | AT erratumstylopineapotentialnaturalmetabolitetoactivatevascularendothelialgrowthfactorreceptor2vegfr2inosteosarcomatherapy |